Peter Vestergaard Rasmussen & Kristina Bacher Svendsen, Senior Physician, Neurological Department Aarhus University Hospital
The effect of medical cannabis on neuropathic pain and spasticity in patients with MS and patients with spinal cord injury. A multicenter national placebo-controlled study.
Both placebo and active is given as peroral treatment in capsules.
In the initiation phase the medication is increased by 1 capsule every second day.
1. 2,5 mg THC (max dosage 22,5 mg)
2.5 mg CBD (max dosage 45 mg)
3.Combination 2,5 mg THC: 5 mg CBD (max dosage 22,5 mg: 45 mg)
4.Placebo capsules (containing hard fat) (max 10 capsules)
Sinikka Kvamme, Ph.D. stud., Center for Drug Research, Aarhus
Questionnaire survey “The Danes’ use of cannabis as medication”.
The questionnaire contains questions regarding: Motives for use, Replacement effect (in stead of other medication), Patterns in use, Inspiration: ”Becoming a medicinal cannabis user”, Challenges; Availability and stigma, Demographics and attitudes.
Helle Riisgaard, Post.doc. Research Unit for General Practice, Odense
Questionnaire Study “Doctors and Patients’ Experiences, Knowledge and Attitudes towards Medicinal Cannabis”
Jonathan Vela, Doctor, PhD Stud., Rheumatologist Department of Aalborg University Hospital
CBD’s effect on pain and inflammation in patients with palpitations and psoriasis arthritis. Placebo-controlled study.
Karoline Hesthaven, Research Assistant, Center for Clinical Research, Regional Hospital Nordjylland
Retrospective study of patients followed in the Pain Clinic by Specialist Tina Horsted.
Peter Leutscher, Professor, MD, PhD Center for Clinical Research, Region Hospital Nordjylland
Nordjysk Medical Cannabinoid Project – a study of cancer patients’ reaction to cannabis as a supplement to conventional palliative treatment.
The study contains: Qualitative research interview, Questionnaire, Open-label study, Randomised, doubleblinded, placebo-controlled study of the same magistrelly made THC 25mg + CBD 50mg/ml oil as well as serum concentrations of cannabinoids.
Oliver Hendricks Chief of Specialists, Research Director, PhD, King Christian X’s Gigthospital Project CAN-ART.
A double-blind, randomized, placebo-controlled study investigating the effect and safety of cannabis in rheumatoid arthritis and back pain. CBD and THC.
Søren Sindrup & Kanita Zubcevic, Senior Doctor & PhD. stud., Neurological Department, Odense University Hospital
THC / CBD for pain relief in peripheral neuropathic pain
Gregers Wegener, Aarhus Universitet, Psykiatrisk Hospital
Understanding the therapeutic mechanisms of Cannabidiol in Depression. CBD tested on animals. Ground research.
Janne Kudsk Klitgaard, SDU
Can parts of the cannabis plant prevent multidrug resistance?
Marianne Uggen Rasmussen, ph.d., Frederiksberg Hospital
Does CBD help sleep and inflammatory pain in fibromyalgy patients?
The research project is gold standard, randomised, blinded and with a placebo control group. Expected participation of app. patients, who will receive CBD or placebo for 24 weeks.
Carsten Hjorthøj, senior researcher at Psychiatric Center Copenhagen. Study on effect on the indication for which the medicinal cannabis is prescribed.
Gitte Handberg, Chief physician at Pain Center South Odense University Hospital and chairman of Danish Forum for Pain a.o. Case-control study that is to collect data from patient files regarding the effect of the treatment with medicinal cannabis.
Jens Søndergaard, research leader, Professor, ph.d. in clinical pharmacology, physician at Syddansk University. Project that aims to evaluate patients´treatment, use and experienced effect of medicinal cannabis.
New Danish research study on early stages of psychosis and out-phasing cannabis abuse with CBD.
Chief Clinician Lone Baandrup, Psychiatric Center Copenhagen has recieved 1,22 mio. DKK from Region Hovedstaden to examine Cannabidiol for treatment of early stages of psychosis and a simultaneous cannabis abuse.
Read more here (in Danish)